Skip to main content

Table 1 Demographics and clinical characteristics of HCC patients before and after one-to-one propensity score matching analysis

From: Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

Variables All patients Propensity-matched patients
HR (n = 280) TACE (n = 899) P value HR (n = 244) TACE (n = 244) P value
Year of treatment (−09/10-) [n (%)] 169(60)/111(40) 359(40)/540(60) < 0.001 137(56)/107(44) 141(58)/103(42) 0.715
Age (y) 48.77 ± 12.90 51.04 ± 11.47 0.009 49.5 ± 13.0 48.9 ± 11.9 0.584
Gender (male/female) [n (%)] 254(91)/26(9) 826(92)/73(8) 0.539 222(91)/22 (9) 215(88)/29 (12) 0.300
Etiology (HBV related/none) [n (%)] 245 (88)/35(12) 810 (90)/89 (10) 0.216 212 (87)/ 32(13) 209 (86)/35(14) 0.693
PLT (109/L) 204.9 ± 81.9 199.8 ± 88.8 0.395 200.9 ± 80.0 197.4 ± 79.0 0.622
PT (sec) 12.3 ± 1.2 12.7 ± 1.4 < 0.001 12.3 ± 1.2 12.3 ± 1.3 0.955
AST (U/L) 55.4 ± 39.5 80.7 ± 65.3 < 0.001 56.7 ± 41.2 60.3 ± 30.9 0.271
ALB (g/L) 41.1 ± 4.0 40.0 ± 4.2 < 0.001 41.0 ± 3.8 41.1 ± 4.0 0.769
TBIL (μmol/L) 19.8 ± 40.4 18.2 ± 12.1 0.525 16.1 ± 18.3 17.8 ± 17.9 0.298
C-P grade (A/B) [n (%)] 273(98)/7(2) 851(95)/48(5) 0.049 240(98)/4 (2) 238(98)/6 (2) 0.523
ALBI (level 1/level 2–3) [n (%)] 193(69)/87(31) 469(52)/430(48) < 0.001 165(68)/79 (32) 161(66)/83(34) 0.701
AFP (≤ 400 μg/L / > 400 μg/L) [n (%)] 127(45)/153(55) 402(45)/497(55) 0.851 113(46)/131(54) 115(47)/129 (53) 0.856
Tumor size (cm) 8.5 ± 3.2 9.5 ± 3.2 < 0.001 9.0 ± 3.1 8.6 ± 3.2 0.147
Tumor numbers (1/2-) [n (%)] 119(43)/161(57) 175(19)/724(81) < 0.001 88/156 (36/64) 85/159 (35/65) 0.776
UICC stage (IIIa / IIIb) [n (%)] 136(49)/144(51) 502(56)/397(44) 0.033 129(53)/115(47) 134(55)/110(45) 0.650
  1. Variables are expressed as mean ± SD or no. (%), unless otherwise indicated
  2. Abbreviations: TACE transarterial chemoembolization, HR hepatic resection, HBV hepatitis B virus, PLT platelet count, PT prothrombin time, AST aspartate aminotransferase, ALB albumin, TBIL total bilirubin, C-P Child-Pugh, ALBI albumin–bilirubin, AFP alpha-fetoprotein, UICC the Union for International Cancer Control